Skip to main content
Top
Published in: Cancer Cell International 1/2019

Open Access 01-12-2019 | Ovarian Cancer | Primary research

Exosomal microRNA-205 is involved in proliferation, migration, invasion, and apoptosis of ovarian cancer cells via regulating VEGFA

Authors: Lijun Wang, Fei Zhao, Zhongqing Xiao, Liang Yao

Published in: Cancer Cell International | Issue 1/2019

Login to get access

Abstract

Background

Recently, the impact of microRNAs (miRNAs) and exosome on ovarian cancer has been assessed in many studies. We aim to explore the mechanism of exosomes transferring miR-205 in ovarian cancer, and confirm its diagnostic value in ovarian cancer.

Methods

The expression of miR-205 of ovarian cancer patients and healthy people was detected by RT-qPCR, and the diagnostic value of miR-205 was evaluated. The exosomes derived from SKOV3 cells were identified. Ovarian cancer SKOV3 donor cells and receptor cells were used to measure the proliferation, migration, invasion, apoptosis and cell cycle by a series of experiments. The binding site between miR-205 and vascular endothelial growth factor A (VEGFA) was evaluated by bioinformatics tool and dual-luciferase reporter gene assay.

Results

MiR-205 was up-regulated in ovarian cancer, and up-regulated miR-205 could enhance the risk of ovarian cancer and was one of its risk factors. After SKOV3 cells-derived exosomes were transiently introduced with miR-205 mimics, the cell proliferation, migration and invasion in ovarian cancer were elevated, the apoptosis of ovarian cancer cells was attenuated, and the epithelial–mesenchymal transition (EMT) protein E-cadherin was down-regulated, while Vimentin was elevated. VEGFA was identified to be a target gene of miR-205.

Conclusion

This study suggests that exosomes from donor ovarian cancer cell SKOV3 shuttled miR-205 could participate in the regulation of the proliferation, migration, invasion, apoptosis as well as EMT progression of receptor SKOV3 cells by targeting VEGFA.
Literature
1.
go back to reference Gao MQ, et al. CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene. 2010;29(18):2672–80.CrossRef Gao MQ, et al. CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene. 2010;29(18):2672–80.CrossRef
2.
go back to reference van Dam GM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 2011;17(10):1315–9.CrossRef van Dam GM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 2011;17(10):1315–9.CrossRef
3.
go back to reference Kazerouni N, et al. Family history of breast cancer as a risk factor for ovarian cancer in a prospective study. Cancer. 2006;107(5):1075–83.CrossRef Kazerouni N, et al. Family history of breast cancer as a risk factor for ovarian cancer in a prospective study. Cancer. 2006;107(5):1075–83.CrossRef
4.
go back to reference Bull CJ, Yarmolinsky J, Wade KH. Commentary: mendelian randomization analysis identifies circulating vitamin D as a causal risk factor for ovarian cancer. Int J Epidemiol. 2016;45(5):1631–3.CrossRef Bull CJ, Yarmolinsky J, Wade KH. Commentary: mendelian randomization analysis identifies circulating vitamin D as a causal risk factor for ovarian cancer. Int J Epidemiol. 2016;45(5):1631–3.CrossRef
5.
go back to reference Delort L, et al. Central adiposity as a major risk factor of ovarian cancer. Anticancer Res. 2009;29(12):5229–34.PubMed Delort L, et al. Central adiposity as a major risk factor of ovarian cancer. Anticancer Res. 2009;29(12):5229–34.PubMed
6.
go back to reference Kobayashi M, et al. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200. J Transl Med. 2014;12:4.CrossRef Kobayashi M, et al. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200. J Transl Med. 2014;12:4.CrossRef
7.
go back to reference Bhattacharya R, et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009;69(23):9090–5.CrossRef Bhattacharya R, et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009;69(23):9090–5.CrossRef
8.
go back to reference Liu G, et al. MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer. J Pathol. 2014;233(3):308–18.CrossRef Liu G, et al. MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer. J Pathol. 2014;233(3):308–18.CrossRef
9.
go back to reference Wiklund ED, et al. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer. 2011;128(6):1327–34.CrossRef Wiklund ED, et al. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer. 2011;128(6):1327–34.CrossRef
10.
go back to reference Mondal G, et al. EGFR-targeted cationic polymeric mixed micelles for codelivery of gemcitabine and miR-205 for treating advanced pancreatic cancer. Mol Pharm. 2017;14(9):3121–33.CrossRef Mondal G, et al. EGFR-targeted cationic polymeric mixed micelles for codelivery of gemcitabine and miR-205 for treating advanced pancreatic cancer. Mol Pharm. 2017;14(9):3121–33.CrossRef
11.
go back to reference Childs G, et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol. 2009;174(3):736–45.CrossRef Childs G, et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol. 2009;174(3):736–45.CrossRef
12.
go back to reference Dusilkova N, et al. Plasma miR-155, miR-203, and miR-205 are biomarkers for monitoring of primary cutaneous T-cell lymphomas. Int J Mol Sci 2017;18(10):2136.CrossRef Dusilkova N, et al. Plasma miR-155, miR-203, and miR-205 are biomarkers for monitoring of primary cutaneous T-cell lymphomas. Int J Mol Sci 2017;18(10):2136.CrossRef
13.
go back to reference Li J, et al. Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression. Sci Rep. 2017;7:41330.CrossRef Li J, et al. Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression. Sci Rep. 2017;7:41330.CrossRef
14.
go back to reference Wei J, et al. MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer. J Ovarian Res. 2017;10(1):33.CrossRef Wei J, et al. MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer. J Ovarian Res. 2017;10(1):33.CrossRef
15.
go back to reference Wang W, et al. The value of plasma-based MicroRNAs as diagnostic biomarkers for ovarian cancer. Am J Med Sci. 2019;358(4):256–67.CrossRef Wang W, et al. The value of plasma-based MicroRNAs as diagnostic biomarkers for ovarian cancer. Am J Med Sci. 2019;358(4):256–67.CrossRef
16.
go back to reference Zhang M, et al. Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls. Cancer Lett. 2019;459:168–75.CrossRef Zhang M, et al. Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls. Cancer Lett. 2019;459:168–75.CrossRef
17.
go back to reference Li J, et al. The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion. Gynecol Oncol. 2015;137(1):125–33.CrossRef Li J, et al. The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion. Gynecol Oncol. 2015;137(1):125–33.CrossRef
18.
go back to reference Dinkins MB, et al. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease. Neurobiol Aging. 2014;35(8):1792–800.CrossRef Dinkins MB, et al. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease. Neurobiol Aging. 2014;35(8):1792–800.CrossRef
19.
go back to reference Zhao Z, et al. A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. Lab Chip. 2016;16(3):489–96.CrossRef Zhao Z, et al. A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. Lab Chip. 2016;16(3):489–96.CrossRef
20.
go back to reference Morelli AE, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004;104(10):3257–66.CrossRef Morelli AE, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004;104(10):3257–66.CrossRef
21.
go back to reference Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509–24.CrossRef Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509–24.CrossRef
22.
go back to reference Karaayvaz M, et al. Prognostic significance of miR-205 in endometrial cancer. PLoS ONE. 2012;7(4):e35158.CrossRef Karaayvaz M, et al. Prognostic significance of miR-205 in endometrial cancer. PLoS ONE. 2012;7(4):e35158.CrossRef
23.
go back to reference Huo L, et al. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol. 2016;29(4):330–46.CrossRef Huo L, et al. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol. 2016;29(4):330–46.CrossRef
24.
go back to reference Su N, et al. miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma. Oncol Rep. 2013;29(6):2297–302.CrossRef Su N, et al. miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma. Oncol Rep. 2013;29(6):2297–302.CrossRef
25.
go back to reference Xie H, et al. miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS ONE. 2012;7(10):e46990.CrossRef Xie H, et al. miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS ONE. 2012;7(10):e46990.CrossRef
26.
go back to reference Mao Y, et al. MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling. J Int Med Res. 2016;44(2):231–40.CrossRef Mao Y, et al. MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling. J Int Med Res. 2016;44(2):231–40.CrossRef
27.
go back to reference Jin C, Liang R. miR-205 promotes epithelial–mesenchymal transition by targeting AKT signaling in endometrial cancer cells. J Obstet Gynaecol Res. 2015;41(10):1653–60.CrossRef Jin C, Liang R. miR-205 promotes epithelial–mesenchymal transition by targeting AKT signaling in endometrial cancer cells. J Obstet Gynaecol Res. 2015;41(10):1653–60.CrossRef
28.
go back to reference Wang B, et al. miR-375 and miR-205 regulate the invasion and migration of laryngeal squamous cell carcinoma synergistically via AKT-mediated EMT. Biomed Res Int. 2016;2016:9652789.PubMedPubMedCentral Wang B, et al. miR-375 and miR-205 regulate the invasion and migration of laryngeal squamous cell carcinoma synergistically via AKT-mediated EMT. Biomed Res Int. 2016;2016:9652789.PubMedPubMedCentral
29.
go back to reference Duan B, et al. miR-205 as a biological marker in non-small cell lung cancer. Biomed Pharmacother. 2017;91:823–30.CrossRef Duan B, et al. miR-205 as a biological marker in non-small cell lung cancer. Biomed Pharmacother. 2017;91:823–30.CrossRef
30.
go back to reference Hu Y, et al. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer. Cell Death Dis. 2016;7(6):e2291.CrossRef Hu Y, et al. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer. Cell Death Dis. 2016;7(6):e2291.CrossRef
31.
go back to reference Xu C, et al. MicroRNA-205 suppresses the invasion and epithelial–mesenchymal transition of human gastric cancer cells. Mol Med Rep. 2016;13(6):4767–73.CrossRef Xu C, et al. MicroRNA-205 suppresses the invasion and epithelial–mesenchymal transition of human gastric cancer cells. Mol Med Rep. 2016;13(6):4767–73.CrossRef
32.
go back to reference Vaksman O, et al. Exosome-derived miRNAs and ovarian carcinoma progression. Carcinogenesis. 2014;35(9):2113–20.CrossRef Vaksman O, et al. Exosome-derived miRNAs and ovarian carcinoma progression. Carcinogenesis. 2014;35(9):2113–20.CrossRef
33.
go back to reference Kim M, et al. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug. Oncogene. 2017;36(36):5199–211.CrossRef Kim M, et al. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug. Oncogene. 2017;36(36):5199–211.CrossRef
Metadata
Title
Exosomal microRNA-205 is involved in proliferation, migration, invasion, and apoptosis of ovarian cancer cells via regulating VEGFA
Authors
Lijun Wang
Fei Zhao
Zhongqing Xiao
Liang Yao
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2019
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-019-0990-z

Other articles of this Issue 1/2019

Cancer Cell International 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine